Esperion Therapeutics Inc (ESPR)
R&D Expenses
$8.99M
Quarterly · Period ending: · USD
ESPR R&D Expenses
Latest reported$8.99Mperiod ending
Latest reported$8.99Mperiod ending
ESPR Quarterly R&D Expenses ($4.06M → $8.99M)
Quarterly R&D Expenses
High-resolution chart · PNG
ESPR r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 8,988,000 | |
| 13,926,000 | |
| 14,131,000 | |
| 7,238,000 | |
| 12,557,000 | |
| 10,977,000 | |
| 10,397,000 | |
| 11,461,000 | |
| 13,403,000 | |
| 17,742,000 | |
| 14,885,000 | |
| 22,099,000 | |
| 31,381,000 | |
| 33,033,000 | |
| 29,143,000 | |
| 32,432,000 | |
| 24,319,000 | |
| 27,616,000 | |
| 25,331,000 | |
| 25,074,000 | |
| 27,954,000 | |
| 41,964,000 | |
| 35,283,000 | |
| 34,987,000 | |
| 34,702,000 | |
| 38,234,000 | |
| 48,281,000 | |
| 42,788,000 | |
| 46,308,000 | |
| 49,473,000 | |
| 41,551,000 | |
| 39,524,000 | |
| 40,940,000 | |
| 33,439,000 | |
| 40,056,000 | |
| 38,248,000 | |
| 35,860,000 | |
| 24,881,000 | |
| 13,498,000 | |
| 9,698,000 | |
| 9,791,000 | |
| 7,956,000 | |
| 7,247,000 | |
| 7,209,000 | |
| 7,390,000 | |
| 6,200,000 | |
| 7,174,000 | |
| 6,528,000 | |
| 5,400,000 | |
| 7,338,517 | |
| 3,482,673 | |
| 3,100,422 | |
| 2,092,593 | |
| 1,654,282 | |
| 2,456,412 | |
| 2,330,223 | |
| 1,557,211 | |
| 4,473,000 | |
| 6,272,000 | |
| 5,460,000 | |
| 4,992,000 | |
| 5,416,000 | |
| 5,878,000 | |
| 5,705,000 | |
| 5,151,000 | |
| 4,902,000 | |
| 5,391,000 | |
| 5,604,000 | |
| 4,922,000 | |
| 6,701,000 | |
| 6,103,000 | |
| 4,063,357 |